|
US8992984B1
(en)
|
2009-10-21 |
2015-03-31 |
Stc.Unm |
Protocells and their use for targeted delivery of multicomponent cargos to cancer cells
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2857499A1
(en)
|
2010-10-01 |
2015-04-08 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
CN103687590A
(zh)
|
2011-04-28 |
2014-03-26 |
Stc·Unm公司 |
用于靶向给药的多孔纳米颗粒支撑脂双层（原始细胞）及其使用方法
|
|
WO2013012891A1
(en)
|
2011-07-19 |
2013-01-24 |
Stc. Unm |
Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
PT3682905T
(pt)
|
2011-10-03 |
2022-04-07 |
Modernatx Inc |
Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
|
|
ES2923757T3
(es)
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9273305B1
(en)
|
2012-04-25 |
2016-03-01 |
Sandia Corporation |
Cell-based composite materials with programmed structures and functions
|
|
US10835495B2
(en)
|
2012-11-14 |
2020-11-17 |
W. R. Grace & Co.-Conn. |
Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
|
|
AU2013346515B2
(en)
*
|
2012-11-16 |
2017-05-25 |
NuCana plc |
Process for preparing nucleoside prodrugs
|
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
|
WO2014138278A1
(en)
|
2013-03-05 |
2014-09-12 |
The Regents Of The University Of California |
Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
|
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2014201276A1
(en)
|
2013-06-12 |
2014-12-18 |
The Methodist Hospital |
Polycation-functionalized nanoporous silicon carrier for systemic delivery of gene silencing agents
|
|
WO2015013352A2
(en)
*
|
2013-07-25 |
2015-01-29 |
Patel Hasmukh B |
Nucleoside phosphoramidates and phosphoramidites
|
|
CA2923029A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
WO2015042279A1
(en)
*
|
2013-09-18 |
2015-03-26 |
Stc. Unm |
Torroidal mesoporous silica nanoparticles (tmsnps) and related protocells
|
|
EP3046547A4
(en)
*
|
2013-09-18 |
2017-05-24 |
Stc.Unm |
Core and surface modification of mesoporous silica nanoparticles to achieve cell specific targeting in vivo
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
US9474720B2
(en)
|
2013-11-04 |
2016-10-25 |
BioPharmX, Inc. |
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
|
|
CA2943109A1
(en)
*
|
2014-01-17 |
2015-07-23 |
Nariyoshi Shinomiya |
Molecule associated with onset of gout, and method and kit for evaluating diathesis of uric acid-related disease and inflammation-related diseases, and inspection object and drug
|
|
WO2016011226A1
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2016013751A1
(ko)
|
2014-07-22 |
2016-01-28 |
주식회사 레모넥스 |
생리활성 물질 또는 단백질 전달용 조성물 및 이의 용도
|
|
EP3171895A1
(en)
|
2014-07-23 |
2017-05-31 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
US20160090603A1
(en)
*
|
2014-09-30 |
2016-03-31 |
Sandia Corporation |
Delivery platforms for the domestication of algae and plants
|
|
AU2015342968B2
(en)
|
2014-11-05 |
2021-05-27 |
Selecta Biosciences, Inc. |
Methods and compositions related to the use of low HLB surfactants in the production of synthetic nanocarriers comprising a rapalog
|
|
WO2016145031A1
(en)
*
|
2015-03-09 |
2016-09-15 |
Stc.Unm |
Cd 47 containing porous nanoparticle supported lipid bilayers (protocells)
|
|
ES2908374T3
(es)
*
|
2015-04-24 |
2022-04-28 |
Colgate Palmolive Co |
Partículas proteicas porosas como portadoras de sustancias activas
|
|
WO2017008059A1
(en)
*
|
2015-07-09 |
2017-01-12 |
The Regents Of The University Of California |
Fusogenic liposome-coated porous silicon nanoparticles
|
|
MA42502A
(fr)
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
US10624949B1
(en)
|
2015-07-27 |
2020-04-21 |
National Technology & Engineering Solutions Of Sandia, Llc |
Methods for treating diseases related to the wnt pathway
|
|
HRP20220156T1
(hr)
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
|
US11219694B2
(en)
*
|
2015-09-24 |
2022-01-11 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for reducing metastases
|
|
CN105174211B
(zh)
*
|
2015-10-12 |
2017-02-01 |
海南大学 |
一种具有表面增强拉曼活性银基复合纳米材料的制备方法及其所得产品和应用
|
|
DE20164728T1
(de)
|
2015-10-22 |
2021-09-30 |
Modernatx, Inc. |
Impfstoffe gegen atemwegsvirus
|
|
WO2017070624A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Tropical disease vaccines
|
|
SG11201803360UA
(en)
|
2015-10-22 |
2018-05-30 |
Modernatx Inc |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
MA45209A
(fr)
|
2015-10-22 |
2019-04-17 |
Modernatx Inc |
Vaccins contre les maladies sexuellement transmissibles
|
|
JP6667896B2
(ja)
*
|
2015-11-06 |
2020-03-18 |
国立研究開発法人産業技術総合研究所 |
リボ核酸固定化担体及びそれを用いたリボ核酸の分離回収方法
|
|
DK3386484T3
(da)
|
2015-12-10 |
2022-07-04 |
Modernatx Inc |
Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
|
|
RS63051B1
(sr)
|
2015-12-22 |
2022-04-29 |
Modernatx Inc |
Jedinjenja i kompozicije za intracelularnu isporuku agenasa
|
|
SMT202200310T1
(it)
|
2015-12-23 |
2022-09-14 |
Modernatx Inc |
Metodi di utilizzo dei polinucleotidi codificanti il ligando di ox40
|
|
WO2017120537A1
(en)
*
|
2016-01-08 |
2017-07-13 |
The Regents Of The University Of California |
Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
|
|
WO2017120504A1
(en)
*
|
2016-01-08 |
2017-07-13 |
Durfee Paul N |
Osteotropic nanoparticles for prevention or treatment of bone metastases
|
|
US20190241658A1
(en)
|
2016-01-10 |
2019-08-08 |
Modernatx, Inc. |
Therapeutic mRNAs encoding anti CTLA-4 antibodies
|
|
CN109843301B
(zh)
*
|
2016-04-14 |
2022-05-27 |
斯宾纳克生物科学公司 |
用于递送治疗剂的含金属硅酸盐的多孔硅材料
|
|
EP3235908A1
(en)
*
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
AU2017295704B2
(en)
*
|
2016-07-13 |
2023-07-13 |
President And Fellows Of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
EP3269444A1
(en)
*
|
2016-07-14 |
2018-01-17 |
Base4 Innovation Ltd |
Method of identifying droplets in a stack and an associated sequencer
|
|
EP3538067A1
(en)
|
2016-11-08 |
2019-09-18 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
MA46766A
(fr)
|
2016-11-11 |
2019-09-18 |
Modernatx Inc |
Vaccin antigrippal
|
|
EP3551193A4
(en)
|
2016-12-08 |
2020-08-19 |
Modernatx, Inc. |
NUCLEIC ACID VACCINES AGAINST RESPIRATORY VIRUSES
|
|
LU100023B1
(en)
*
|
2017-01-20 |
2018-07-30 |
Luxembourg Inst Science & Tech List |
Nanocapsules and method for manufacturing thereof
|
|
CN106822916B
(zh)
*
|
2017-01-25 |
2020-02-28 |
浙江大学 |
一种pH敏感的纳米化Bcl-2选择性抑制剂的制备方法及产物和应用
|
|
KR102627347B1
(ko)
|
2017-01-27 |
2024-01-22 |
더 메서디스트 하스피틀 |
면역 요법을 위한 코어/쉘 구조 플랫폼
|
|
JP6883354B2
(ja)
|
2017-02-06 |
2021-06-09 |
レモネックス インコーポレイテッドＬｅｍｏｎｅｘ Ｉｎｃ． |
生理活性物質送達体
|
|
US11344629B2
(en)
|
2017-03-01 |
2022-05-31 |
Charles Jeffrey Brinker |
Active targeting of cells by monosized protocells
|
|
WO2018170270A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Varicella zoster virus (vzv) vaccine
|
|
JP7332478B2
(ja)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子製剤
|
|
RS63953B1
(sr)
|
2017-03-15 |
2023-02-28 |
Modernatx Inc |
Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
|
|
WO2018170260A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Respiratory syncytial virus vaccine
|
|
WO2018170256A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
US11576961B2
(en)
|
2017-03-15 |
2023-02-14 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
WO2018170322A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
EP3638678B1
(en)
|
2017-06-14 |
2025-12-03 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
|
US11007516B1
(en)
|
2017-06-19 |
2021-05-18 |
National Technology & Engineering Solutions Of Sandia, Llc |
Tunable metal-organic framework compositions and methods thereof
|
|
US20210093654A1
(en)
*
|
2017-07-28 |
2021-04-01 |
Lemonex Inc. |
Pharmaceutical composition for preventing or treating liver cancer
|
|
MX2020002348A
(es)
|
2017-08-31 |
2020-10-08 |
Modernatx Inc |
Métodos de elaboración de nanopartículas lipídicas.
|
|
KR102152348B1
(ko)
|
2017-09-05 |
2020-09-08 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
WO2019050283A1
(ko)
*
|
2017-09-05 |
2019-03-14 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
EP3681514A4
(en)
|
2017-09-14 |
2021-07-14 |
ModernaTX, Inc. |
RNA VACZINE AGAINST ZIKA VIRUS
|
|
US10933027B1
(en)
*
|
2017-09-25 |
2021-03-02 |
National Technology & Engineering Solutions Of Sandia, Llc |
Expanded pore particles and delivery methods thereof
|
|
CN107952076A
(zh)
*
|
2017-11-07 |
2018-04-24 |
徐州医科大学 |
一种多囊脂质体/多孔碳纳米复合物、制备方法及应用
|
|
US20200330616A1
(en)
*
|
2017-11-13 |
2020-10-22 |
POLITECNICO Dl TORINO |
Biomimetic non-immunogenic nanoassembly for the antitumor therapy
|
|
US11661599B1
(en)
|
2017-12-14 |
2023-05-30 |
National Technology & Engineering Solutions Of Sandia, Llc |
CRISPR-Cas based system for targeting single-stranded sequences
|
|
EP3735250A4
(en)
|
2018-01-01 |
2022-04-13 |
The Regents Of The University Of California |
UPSCALE SYNTHESIS OF SILICASOME NANOCARRIAGES
|
|
US11911453B2
(en)
|
2018-01-29 |
2024-02-27 |
Modernatx, Inc. |
RSV RNA vaccines
|
|
KR102017110B1
(ko)
|
2018-03-08 |
2019-09-02 |
한국화학연구원 |
구역화된 간소엽 모사체 및 이를 이용한 구역별 간독성 평가방법
|
|
US20200208177A1
(en)
*
|
2018-04-18 |
2020-07-02 |
Ligandal, Inc. |
Methods and compositions for genome editing
|
|
WO2019204666A1
(en)
*
|
2018-04-18 |
2019-10-24 |
Oisin Biotechnologies, Inc. |
Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a disease, condition, or disorder associated with a target cell
|
|
WO2019219721A1
(en)
|
2018-05-18 |
2019-11-21 |
F. Hoffmann-La Roche Ag |
Targeted intracellular delivery of large nucleic acids
|
|
US11045554B1
(en)
|
2018-06-22 |
2021-06-29 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid-coated particles for treating viral infections
|
|
KR102316722B1
(ko)
*
|
2018-08-06 |
2021-10-26 |
주식회사 레모넥스 |
면역반응 물질 전달체
|
|
WO2020037530A1
(en)
*
|
2018-08-22 |
2020-02-27 |
Waterstone Pharmaceuticals (Wuhan) Co., Ltd. |
Crystalline form of compound and uses thereof in medicine
|
|
EP3853202A1
(en)
|
2018-09-19 |
2021-07-28 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
CN112996854B
(zh)
|
2018-09-19 |
2024-08-30 |
摩登纳特斯有限公司 |
高纯度peg脂质和其用途
|
|
US12151029B2
(en)
|
2018-09-19 |
2024-11-26 |
Modernatx, Inc. |
PEG lipids and uses thereof
|
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
US12252708B2
(en)
|
2018-09-24 |
2025-03-18 |
Unm Rainforest Innovations |
Living mammalian cells modified with functional modular nanoparticles
|
|
KR20200051916A
(ko)
*
|
2018-11-05 |
2020-05-14 |
주식회사 메디포럼제약 |
고세렐린을 포함하는 실리카 하이드로겔 조성물
|
|
JP2022514568A
(ja)
|
2018-12-17 |
2022-02-14 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
免疫系のモジュレーションのための生物工学的スキャフォールドおよびその使用
|
|
US20220049216A1
(en)
*
|
2018-12-24 |
2022-02-17 |
Korea University Research And Business Foundation |
Manufacture of structure capable of forming three-dimensional neuronal spheroid and generating neurite through various surface processes
|
|
IT201900001009A1
(it)
|
2019-01-23 |
2020-07-23 |
Torino Politecnico |
Vettore nanoporoso biomimetico comprendente un inibitore diretto verso la forma nativa della proteina IDH2
|
|
CN113939282A
(zh)
|
2019-01-31 |
2022-01-14 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
|
JP7320303B2
(ja)
*
|
2019-02-22 |
2023-08-03 |
レモネックス インコーポレイテッド |
免疫活性もしくは癌の予防または治療用の医薬組成物
|
|
WO2020176716A1
(en)
|
2019-02-28 |
2020-09-03 |
Brinker C Jeffrey |
Modular metal–organic polyhedra superassembly compositions
|
|
MA55321A
(fr)
|
2019-03-15 |
2022-01-19 |
Modernatx Inc |
Vaccins à base d'arn contre le vih
|
|
GB201904334D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
Carrier system for preparing herbaceous extracts
|
|
GB201904337D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
EP3714879A1
(en)
*
|
2019-03-28 |
2020-09-30 |
Sisaf Ltd |
Structured encapsulated silicon-containing particles
|
|
GB201904336D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
WO2020200472A1
(en)
*
|
2019-04-05 |
2020-10-08 |
Biontech Rna Pharmaceuticals Gmbh |
Preparation and storage of liposomal rna formulations suitable for therapy
|
|
US12377118B2
(en)
*
|
2019-08-09 |
2025-08-05 |
Case Western Reserve University |
Nanoparticle constructs for systemic co-delivery of anti-tumor agents
|
|
EP4031524A1
(en)
|
2019-09-19 |
2022-07-27 |
ModernaTX, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
AU2020351220A1
(en)
|
2019-09-19 |
2022-04-07 |
Modernatx, Inc. |
Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
KR20250133471A
(ko)
|
2020-02-18 |
2025-09-05 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 화합물
|
|
TWI775313B
(zh)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
CA3174988A1
(en)
|
2020-03-11 |
2021-09-16 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers
|
|
WO2021189355A1
(en)
*
|
2020-03-26 |
2021-09-30 |
Chinese Institute For Brain Research, Beijing |
Amino acid mediated gene delivery and its uses
|
|
EP4125816A4
(en)
*
|
2020-04-01 |
2024-01-10 |
University of Cincinnati |
MATERIALS AND METHODS FOR CANCER THERAPY TARGETING AN IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT
|
|
US11433121B1
(en)
*
|
2020-04-03 |
2022-09-06 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid composition for the delivery of therapeutic cargos
|
|
CN113713115B
(zh)
*
|
2020-05-22 |
2023-11-24 |
青岛科技大学 |
一种采用碳多孔材料构建抗癌载药系统的方法
|
|
GB2600704A
(en)
*
|
2020-11-04 |
2022-05-11 |
Sumitomo Chemical Co |
Nanoparticle
|
|
EP4247347A4
(en)
*
|
2020-11-30 |
2024-05-22 |
Ege Universitesi |
TARGETED NANOPARTICLES WITH TWO ACTIVE INGREDIENTS IN THE TREATMENT OF MELANOMAS
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
CN112870387B
(zh)
*
|
2021-02-26 |
2023-08-29 |
中山大学孙逸仙纪念医院 |
一种磁性纳米药物载体及其制备方法和应用
|
|
WO2022192674A1
(en)
*
|
2021-03-11 |
2022-09-15 |
The Trustees Of The University Of Pennsylvania |
Targeted therapeutic lipid nanoparticles and methods of use
|
|
CN113149023B
(zh)
*
|
2021-03-11 |
2023-05-02 |
昆明理工大学 |
一种介孔二氧化硅纳米颗粒经皮递送低共熔体系制备方法
|
|
AU2022256476B2
(en)
|
2021-04-16 |
2025-06-05 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
|
BR112023021962A2
(pt)
*
|
2021-04-22 |
2023-12-26 |
Perseo Pharma Ag |
Composições biocatalíticas funcionalizadas
|
|
CN113082226B
(zh)
*
|
2021-04-27 |
2023-12-15 |
山东中医药大学 |
一种载药纳米笼的制备方法与其靶向循环肿瘤细胞释放雷公藤甲素的应用
|
|
CA3228162A1
(en)
|
2021-08-18 |
2023-02-23 |
Gilead Sciences, Inc. |
Phospholipid compounds and methods of making and using the same
|
|
CN113735350B
(zh)
*
|
2021-09-23 |
2023-01-24 |
深圳市水务规划设计院股份有限公司 |
一种黑臭水体处理工艺及其实验装置
|
|
JP7717252B2
(ja)
*
|
2021-10-13 |
2025-08-01 |
タンペレ・ユニバーシティー・ファウンデーション・エスアール |
細胞培養システム
|
|
CN114129718B
(zh)
*
|
2021-10-19 |
2024-05-03 |
华东师范大学 |
一种用于体内自组装car-t的纳米递送系统及其制备方法和应用
|
|
US20250327041A1
(en)
|
2022-02-24 |
2025-10-23 |
Io Biotech Aps |
Nucleotide delivery of cancer therapy
|
|
US12145890B2
(en)
|
2022-12-16 |
2024-11-19 |
Raytheon Company |
Coated (core-shell) nanoparticles for nanocomposite optical ceramics
|
|
CN116327975A
(zh)
*
|
2022-12-20 |
2023-06-27 |
中国科学院基础医学与肿瘤研究所(筹) |
一种醋酸棉酚硅脂体及其制备方法和用途
|
|
CN116327985B
(zh)
*
|
2023-02-21 |
2024-09-27 |
武汉工程大学 |
一种具有靶向超声造影成像功能的空心囊泡载药递送系统及其制备方法与应用
|
|
KR102736072B1
(ko)
*
|
2023-05-15 |
2024-12-05 |
주식회사 엠피오스 |
소수성 약물의 서방출용 실리카 기반 나노입자, 이의 제조방법 및 이를 포함하는 경피 약물투여시스템
|
|
EP4520345A1
(en)
|
2023-09-06 |
2025-03-12 |
Myneo Nv |
Product
|
|
CN117535410A
(zh)
*
|
2023-10-26 |
2024-02-09 |
重庆医科大学 |
Ythdf2抑制剂及其与紫杉醇联合使用在制备治疗卵巢癌的药物中的应用
|
|
CN121197436B
(zh)
*
|
2025-10-20 |
2026-05-19 |
湖北大学 |
一种有效跨越血脑屏障的载药胶束及其制备方法、应用
|
|
CN121627809A
(zh)
*
|
2025-11-05 |
2026-03-10 |
中国医学科学院放射医学研究所 |
一种相分离多肽及其在仿生原细胞构建中的应用
|